NTLA earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -3.14. Updated 2026-07-23.
Intellia Therapeutics (NTLA) Research Hub
Intellia Therapeutics (NTLA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 11.26 USD (+0.45%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.14, market cap 1.25B. This hub links to the full technical, earnings and options research available for NTLA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 11.26 USD (+0.45%) |
| 52-week range | 10.15 USD – 18.48 USD |
| Trend regime | Range |
| 14-day RSI | 39 (Bearish) |
| Trailing P/E | -3.14 |
| Market cap | 1.25B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for NTLA
Covered Call on NTLA: how it works, illustrative setup around the real 11.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NTLA: how it works, illustrative setup around the real 11.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NTLA: how it works, illustrative setup around the real 11.26 USD price, max profit/loss, breakeven and when to use it. Educational.
NTLA technical analysis: range, last 11.26 USD, RSI 39, 52w range 10.15 USD–18.48 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NTLA in?
Intellia Therapeutics (NTLA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NTLA in an uptrend or downtrend?
As of 2026-10-26, NTLA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NTLA's trailing P/E ratio?
NTLA's trailing P/E is -3.14, with a market cap of 1.25B. See the earnings research page for full valuation detail.
When does NTLA next report earnings?
NTLA is next scheduled to report earnings on 2026-08-06.